ArticleJournal of medicinal chemistry2022

Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology.

Punit Upadhyaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.